谷野裕一 (Hirokazu Tanino) - マイポータル

基本情報

所属: 神戸大学大学院医学研究科医科学専攻教授

学位: 博士（医学）(和歌山県立医科大学)

J-GLOBAL ID: 201701008904765530
researchmap会員ID: 7000020531

外部リンク: https://breastlife2020.com

研究キーワード

研究分野

ライフサイエンス / 腫瘍診断、治療学 / 乳腺外科、乳がん、トリプルネガティブ乳がん、化学療法、

学歴

- 1987年3月

和歌山県立医科大学卒業

論文

A Universal Gelfoam 3-D Histoculture Method to Establish Patient-derived Cancer Cells (3D-PDCC) Without Fibroblasts from Patient-derived Xenografts.

Jun Yamamoto, Norihiko Sugisawa, Kazuyuki Hamada, Hiroto Nishino, Kentaro Miyake, Ryusei Matsuyama, Sachiko Inubushi, Hirokazu Tanino, Michael Bouvet, Itaru Endo, Robert M Hoffman

Anticancer research 40(12) 6765-6768 2020年12月
Co-implantation of Tumor and Extensive Surrounding Tissue Improved the Establishment Rate of Surgical Specimens of Human-Patient Cancer in Nude Mice: Toward the Goal of Universal Individualized Cancer Therapy

Takuya Murata, Chihiro Hozumi, Yukihiko Hiroshima, Koichiro Shimoya, Atsushi Hongo, Sachiko Inubushi, Hirokazu Tanino, Robert M. Hoffman

IN VIVO 34(6) 3241-3245 2020年11月
Oncogenic miRNAs Identified in Tear Exosomes From Metastatic Breast Cancer Patients.

Sachiko Inubushi, Hiroki Kawaguchi, Sachiko Mizumoto, Tomonari Kunihisa, Motoi Baba, Yukiya Kitayama, Toshifumi Takeuchi, Robert M Hoffman, Hirokazu Tanino, Ryohei Sasaki

Anticancer research 40(6) 3091-3096 2020年6月
Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model.

Jun Yamamoto, Takuya Murata, Norihiko Sugisawa, Takashi Higuchi, Yoshihiko Tashiro, Hiroto Nishino, Sachiko Inubushi, Y U Sun, Hyein Lim, Kentaro Miyake, Koichiro Shimoya, Tsunehisa Nomura, Junichi Kurebayashi, Hirokazu Tanino, Chihiro Hozumi, Michael Bouvet, Shree Ram Singh, Itaru Endo, Robert M Hoffman

Anticancer research 40(5) 2475-2479 2020年5月査読有り
A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib.

Jun Yamamoto, Takuya Murata, Yoshihiko Tashiro, Takashi Higuchi, Norihiko Sugisawa, Hiroto Nishino, Sachiko Inubushi, Y U Sun, Hyein Lim, Kentaro Miyake, Atsushi Hongo, Tsunehisa Nomura, Wataru Saitoh, Takuya Moriya, Hirokazu Tanino, Chihiro Hozumi, Michael Bouvet, Shree Ram Singh, Itaru Endo, Robert M Hoffman

Anticancer research 40(5) 2509-2514 2020年5月査読有り
Antibody-Conjugated Signaling Nanocavities Fabricated by Dynamic Molding for Detecting Cancers Using Small Extracellular Vesicle Markers from Tears

Toshifumi Takeuchi, Kisho Mori, Hirobumi Sunayama, Eri Takano, Yukiya Kitayama, Taku Shimizu, Yuzuki Hirose, Sachiko Inubushi, Ryohei Sasaki, Hirokazu Tanino

Journal of the American Chemical Society 142(14) 6617-6624 2020年4月8日
Risk Analysis for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving FEC100 Treatment.

Mitsuhiro Hayashi, Kyoko Nakazawa, Yoshie Hasegawa, Jun Horiguchi, Daishu Miura, Takashi Ishikawa, Shintaro Takao, Seung Jim Kim, Kazuhiko Yamagami, Masaru Miyashita, Muneharu Konishi, Yasushi Shigeoka, Masato Suzuki, Tetsuya Taguchi, Tomoyuki Kubota, Hirokazu Tanino, Kimito Yamada, Kazutaka Narui, Konomi Kimura, Kohei Akazawa, Norio Kohno

Anticancer research 39(8) 4305-4314 2019年8月査読有り
Clinical usefulness of the histoculture drug response assay for breast cancer

Robert M. Hoffman, Hirokazu Tanino

Methods in Molecular Biology 1760 93-100 2018年査読有り
Survival outcomes of neoadjuvant chemotherapy with zoledronic acid for HER2-negative breast cancer

Takashi Ishikawa, Kouhei Akazawa, Yoshie Hasegawa, Hirokazu Tanino, Jun Horiguchi, Daishu Miura, Mitsuhiro Hayashi, Norio Kohno

JOURNAL OF SURGICAL RESEARCH 220 46-51 2017年12月査読有り
広範なDCISを伴った乳腺腺様嚢胞癌の1例

下村実貴子, 仙石紀彦, 古藤里佳, 鯉江めぐみ, 南谷菜穂子, 菊地真理子, 西宮洋史, 小坂愉賢, 藁谷美奈, 加藤弘, 榎本拓茂, 梶田咲美乃, 谷野裕一, 渡邊昌彦

神奈川医学会雑誌 44(2) 196-197 2017年7月
Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015

Jun Yamamura, Norikazu Masuda, Daigo Yamamoto, Shigeru Tsuyuki, Masahide Yamaguchi, Satoru Tanaka, Junji Tsurutani, Shinya Tokunaga, Katsuhide Yoshidome, Makiko Mizutani, Toyokazu Aono, Asako Ooe, Hirokazu Tanino, Nobuki Matsunami, Hiroyuki Yasojima, Takahiro Nakayama, Yukihiro Nishida

CHEMOTHERAPY 62(5) 307-313 2017年査読有り
Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer

Mariko Kikuchi, Hiroshi Katoh, Mina Waraya, Yoko Tanaka, Satoru Ishii, Toshimichi Tanaka, Nobuyuki Nishizawa, Keigo Yokoi, Naoko Minatani, Akira Ema, Yoshimasa Kosaka, Hirokazu Tanino, Keishi Yamashita, Masahiko Watanabe

CANCER LETTERS 384 70-78 2017年1月査読有り
BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Hirokazu Tanino, Yoshimasa Kosaka, Hiroshi Nishimiya, Youko Tanaka, Naoko Minatani, Mariko Kikuchi, Akiko Shida, Mina Waraya, Hiroshi Katoh, Takumo Enomoto, Norihiko Sengoku, Sabine Kajita, Robert M. Hoffman, Masahiko Watanabe

PLOS ONE 11(12) 2016年12月査読有り
Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy

Yoshimasa Kosaka, Hirokazu Tanino, Norihiko Sengoku, Naoko Minatani, Mariko Kikuchi, Hiroshi Nishimiya, Mina Waraya, Hiroshi Katoh, Takumo Enomoto, Takeo Sato, Masaru Kuranami, Masahiko Watanabe

SUPPORTIVE CARE IN CANCER 24(3) 1405-1411 2016年3月査読有り
Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer

Naoko Minatani, Mina Waraya, Keishi Yamashita, Mariko Kikuchi, Hideki Ushiku, Ken Kojo, Akira Ema, Hiroshi Nishimiya, Yoshimasa Kosaka, Hiroshi Katoh, Norihiko Sengoku, Hirokazu Tanino, David Sidransky, Masahiko Watanabe

PLOS ONE 11(1) 2016年1月査読有り
Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer

Mariko Kikuchi, Keishi Yamashita, Mina Waraya, Naoko Minatani, Hideki Ushiku, Ken Kojo, Akira Ema, Yoshimasa Kosaka, Hiroshi Katoh, Norihiko Sengoku, Takumo Enomoto, Hirokazu Tanino, Masakazu Sawanobori, Masahiko Watanabe

ONCOTARGET 7(2) 1741-1753 2016年1月査読有り
Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study)

Yoshie Hasegawa, Hirokazu Tanino, Jun Horiguchi, Daishu Miura, Takashi Ishikawa, Mitsuhiro Hayashi, Shintaro Takao, Seung Jin Kim, Kazuhiko Yamagami, Masaru Miyashita, Muneharu Konishi, Yasushi Shigeoka, Masato Suzuki, Tetsuya Taguchi, Tomoyuki Kubota, Kouhei Akazawa, Norio Kohno

PLOS ONE 10(12) 2015年12月査読有り
Usefulness of MRI of Microcalcification Lesions to Determine the Indication for Stereotactic Mammotome Biopsy

Mariko Kikuchi, Hirokazu Tanino, Yoshimasa Kosaka, Norihiko Sengoku, Keishi Yamashita, Naoko Minatani, Hiroshi Nishimiya, Mina Waraya, Hiroshi Katoh, Takumo Enomoto, Sabine Kajita, Reiko Woodhams, Masahiko Watanabe

ANTICANCER RESEARCH 34(11) 6749-6753 2014年11月査読有り
The Safety of Concentrated Trastuzumab in 100 ml of Saline Solution for Administration to Patients with HER2-Positive Breast Cancer: A Phase 1 Study

Norihiko Sengoku, Hirokazu Tanino, Yoshimasa Kosaka, Mariko Kikuchi, Hiroshi Nishimiya, Mina Waraya, Hiroshi Katoh, Takumo Enomoto, Takeo Sato, Masaru Kuranami, Masahiko Watanabe

CHEMOTHERAPY 60(1) 1-6 2014年査読有り
Prognostic Significance of Ki-67 in Chemotherapy-naive Breast Cancer Patients with 10-year Follow-up

Hiroshi Nishimiya, Yoshimasa Kosaka, Keishi Yamashita, Naoko Minatani, Mariko Kikuchi, Akira Ema, Kazunori Nakamura, Mina Waraya, Norihiko Sengoku, Hirokazu Tanino, Masaru Kuranami, Watanabe Masahiko

ANTICANCER RESEARCH 34(1A) 259-268 2014年1月査読有り

MISC

Oncogenic miRNAs Identified in Tear Exosomes From Metastatic Breast Cancer Patients (vol 40, pg 3091, 2020)

Sachiko Inubushi, Hiroki Kawaguchi, Sachiko Mizumoto, Tomonari Kunihisa, Motoi Baba, Yukiya Kitayama, Toshifumi Takeuchi, Robert M. Hoffman, Hirokazu Tanino, Ryohei Sasaki

ANTICANCER RESEARCH 40(8) 4805-4805 2020年8月
Lymph node metastasis and high serum CEA are important prognostic factors in hormone receptor positive and HER2 negative breast cancer.

Yoshimasa Kosaka, Naoko Minatani, Yoko Tanaka, Akiko Shida, Mariko Kikuchi, Hiroshi Nishimiya, Mina Waraya, Hiroshi Katoh, Takeo Sato, Norihiko Sengoku, Hirokazu Tanino, Keishi Yamashita, Masahiko Watanabe

Molecular and clinical oncology 9(5) 566-574 2018年11月
Examination about febrile neutropenia in patient performed FEC with breast cancer

Mariko Kikuchi, Mina Waraya, Naoko Minatani, Hiroshi Nishimiya, Hiroshi Katoh, Masayoshi Kosaka, Takumo Enomoto, Norihiko Senngoku, Hirokazu Tanino, Masahiko Watanabe

ANNALS OF ONCOLOGY 26 142-143 2015年11月
Exploring biomarkers of response to zoledronic acid in breast cancer from clinical trial result of neoadjuvant chemotherapy with zoledronic acid: JONIE-1 study

Takafumi Sangai, Takashi Ishikawa, Norio Kohno, Daishu Miura, Eiichi Sato, Hiroshi Kaise, Masato Suzuki, Yoshie Hasegawa, Hirokazu Tanino, Jun Horiguchi, Kohei Akazawa

CANCER RESEARCH 75 2015年5月
BRCAness and prognosis in triple-negative breast cancer patients treated with neoadjuvant chemotherapy

Hirokazu Tanino, Yoshimasa Kosaka, Norihiko Sengoku, Mina Waraya, Hiroshi Nishimiya, Hirozhi Katoh, Mariko Kikuchi, Naoko Minatani, Saeko Teraoka, Takumo Enomoto, Takeo Sato, Masahiko Masahiko

CANCER RESEARCH 75 2015年5月
THE COMBINATION CHEMOTHERAPY OF GEMCITABINE AND VINORELBINE IN HER2-NEGATIVE PATIENTS WITH TAXANE-PRETREATED METASTATIC BREAST CANCER: A PHASE II STUDY OF KINKI MULTIDISCIPLINARY BREAST ONCOLOGY GROUP (KMBOG) 1015 (UMIN000004839)

Jun Yamamura, Norikazu Masuda, Daigo Yamamoto, Shigeru Tsuyuki, Masahide Yamaguchi, Satoru Tanaka, Junji Tsurutani, Sinya Tokunaga, Katsuhide Yoshidome, Makiko Mizutani, Toyokazu Aono, Asako Ooe, Hirokazu Tanino, Nobuki Matsunami, Hiroyuki Yasojima, Takahiro Nakayama, Yukihiro Nishida

BREAST 22 S38-S38 2013年11月
A randomized controlled trial comparing zoledronic acid plus chemotherapy with chemotherapy alone as a neoadjuvant treatment in patients with HER2-negative primary breast cancer.

Jun Horiguchi, Yoshie Hasegawa, Daishu Miura, Takashi Ishikawa, Mitsuhiro Hayashi, Shintaro Takao, Seung Jin Kim, Hirokazu Tanino, Masaru Miyashita, Muneharu Konishi, Yasushi Shigeoka, Kazuhiko Yamagami, Kohei Akazawa, Norio Kohno

JOURNAL OF CLINICAL ONCOLOGY 31(15) 2013年5月
Randomized controlled trial comparing zoledronic acid plus chemotherapy with chemotherapy alone as a neoadjuvant treatment in patients with HER2-negative primary breast cancer

Norio Kohno, Yoshie Hasegawa, Jun Horiguchi, Takashi Ishikawa, Daishu Miura, Mitsuhiro Hayashi, Shintaro Takao, Seung Jin Kim, Hirokazu Tanino, Kohei Akazawa

JOURNAL OF CLINICAL ONCOLOGY 30(15) 2012年5月

講演・口頭発表等

Risk analysis for chemotherapy induced nausea and vomiting (CINV) in patients receiving FEC100 treatment

Mitsuhiro Hayashi, Kyoko Nakazawa, Yoshie Hasegawa, Jun Horiguchi, Daishu Miura, Takashi Ishikawa, Shintaro Takao, Seung Jim Kim, Kazuhiko Yamagami, Masaru Miyashita, Muneharu Konishi, Yasushi Shigeoka, Masato Suzuki, Tetsuya Taguchi, Tomoyuki Kubota, Yuichi Tanino, Kimito Yamada, Konomi Kimura, Kohei Akazawa, Norio Kohno

SAN ANTONIO BREAST CANCER SYMPOSIUM 43rd Annual SABCS 2018年12月
Phase 3 trial of carboplatin in triple negative breast cancer (TNBC) patients with residual invasive carcinoma after neoadjuvant chemotherapy (JONIE4:J-CAT trial)

Tanino Hirokazu, Suzuki Masato, Kaise Hiroshi, Miyashita Masaru, Chishima Takashi, Hayashi Mitsuhiro, Miyoshi Yasuo, Futamura Manabu, Ohtani Shoichiro, Nagahashi Masayuki, Ohta Tomohiko, Kosaka Yoshimasa, Ishikawa Takashi, Hasegawa Yoshie, Kubota Tomoyuki, Sangai Takashi, Iwatani Tuguo, Yamada Akimitu, Akazawa Kohei, Kohno Norio

SAN ANTONIO BREAST CANCER SYMPOSIUM 43rd Annual SABCS 2018年12月
BRCAness as a prognostic marker in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: A multicenter retrospective study

Yoshimasa Kosaka, Yutaka Yamamoto, Hiroshi Nishimiya, Mutsuko Ibusuki-Yamamoto, Yuko Hirota, Hirokazu Tanino, Hirotaka Iwase, Seigo Nakamura, Sadako Akashi-Tanaka

SAN ANTONIO BREAST CANCER SYMPOSIUM 43rd Annual SABCS 2018年12月
オラパリブの乳癌適応拡大に向けた当院の取り組み

國久智成, 豊田昌徳, 谷野裕一, 三木万由子, 斎藤明菜, 岡本葵, 杉谷諭奈, 水本紗千子

日本人類遺伝学会第63回大会 2018年10月横浜市立大学大学院医学研究科遺伝学
乳癌切除標本における比誘電率計測と非侵襲マイクロ波散乱場断層イメージングに関する研究

稲垣明里, 木村建次郎, 木村憲明, 土井恭二, 美馬勇輝, 河野誠之, 谷野裕一, 高尾信太郎, 三木万由子, 廣利浩一, 橋本知久, 佐久間淑子, 岡本交二, 渡邊奈津子, 小西豊, 山神和彦, 松本元

第26回日本乳癌学会学術総会 2018年5月
術前化学療法を施行したtriple negative乳癌症例におけるBRCAnessおよびAndrogen Receptorに関する検討

小坂愉賢, 西宮洋史, 横田光央, 菊池真理子, 加藤弘, 梶田咲美乃, 谷野裕一, 仙石紀彦, 渡邊昌彦

第26回日本乳癌学会学術総会 2018年5月株式会社コングレ
再発乳癌の一次化学療法としてTS-1が著効したER陽性HER2陰性男性乳癌の1例

河野誠之, 平尾益美, 杉谷諭奈, 谷野裕一, 高尾信太郎

第26回日本乳癌学会学術総会 2018年5月株式会社コングレ
ER陽性HER2陰性再発・進行乳癌の治療戦略 HER2陰性進行・再発乳癌に対するベバシズマブとパクリタキセル併用療法の前向き観察研究(JBCRG-C05試験)

唐宇飛, 山本豊, 山城大泰, 近藤直人, 中村力也, 柏葉匡寛, 高橋將人, 津川浩一郎, 石川孝, 中山貴寛, 大谷彰一郎, 高野利実, 藤澤知巳, 遠山竜也, 川口英俊, 増野浩二郎, 谷野裕一, 森田智視, 戸井雅和, 大野真司

第26回日本乳癌学会学術総会 2018年5月株式会社コングレ
Development of Microwave Scattered Field Tomographic Imaging System and Clinical Trial Results(プレスリリースセッション)

Kenjiro Kimura, Akari Inagaki, Seishi Kono, Hirokazu Tanino, Tomohisa Hashimoto, Toshiko Sakuma, Mayuko Miki, Shintaro Takao, Natsuko Watanabe, Yutaka Konishi, Koji Okamoto, Hajime Matsumoto, Kazuhiko Yamagami, Yuki Mima, Kyoji Doi, Noriaki Kimura

第26回日本乳癌学会学術総会 2018年5月招待有り
Development of Microwave Scattered Field Tomographic Imaging System and Clinical Trial Results(インターナショナルシンポジウム)

Kenjiro Kimura, Akari Inagaki, Seishi Kono, Hirokazu Tanino, Tomohisa Hashimoto, Toshiko Sakuma, Mayuko Miki, Shintaro Takao, Natsuko Watanabe, Yutaka Konishi, Koji Okamoto, Hajime Matsumoto, Kazuhiko Yamagami, Yuki Mima, Kyoji Doi, Noriaki Kimura

第26回日本乳癌学会学術総会 2018年5月招待有り

谷野裕一

基本情報

研究キーワード

研究分野

学歴

論文

MISC

講演・口頭発表等

メニュー

共著者の一覧